Bin Peng

发表

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

R. Capdeville, B. Peng, A. Bolton, 2004, Cancer Chemotherapy and Pharmacology.

Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study.

A. Racine‐Poon, M. Hensley, I. Gathmann, 2005, British journal of clinical pharmacology.